2020 No. 80
The Human Tissue (Authorisation) (Specified Type A Procedures) (Scotland) Regulations 2020
Made
Coming into force in accordance with regulation 1
The Scottish Ministers make the following Regulations in exercise of the powers conferred by sections 16B(1) and (2) of the Human Tissue (Scotland) Act 2006 M1 and all other powers enabling them to do so.
In accordance with section 16B(4) of that Act they have consulted with such persons as they consider appropriate.
In accordance with section 59(3)(ad) M2 of that Act, a draft of this instrument has been laid before and approved by resolution of the Scottish Parliament.
Section 59(3)(ad) was inserted by 23(2) of the 2019 Act.
Citation and commencementI11
These Regulations may be cited as the Human Tissue (Authorisation) (Specified Type A Procedures) (Scotland) Regulations 2020 and come into force on the day on which section 23 of the Human Tissue (Authorisation) (Scotland) Act 2019 M3 comes into force for all purposes.
Type A proceduresI22
The pre-death procedures specified in the second column of the table in the schedule are specified as Type A procedures for the purposes of sections 16D to 16F of the Human Tissue (Scotland) Act 2006 M4.
SCHEDULESpecification of Pre-Death Procedures
I31
In this schedule—
“arterial line” means a cannula inserted into an artery,
“blood component” means any of the following constituents of human blood—
red cells,
white cells,
platelets, and
plasma,
“blood product” means any therapeutic product derived from human blood or plasma,
“intravenous fluids” means any electrolyte solution intended for intravenous administration,
“pre-established airway and ventilatory support” means any method of airway or ventilatory support administered to the person for the primary purpose of the person's medical treatment prior to any decision to withdraw life sustaining treatment,
“pre-established suprapubic catheter” means a suprapubic catheter inserted into the person for the primary purpose of the person's medical treatment prior to any decision to withdraw life sustaining treatment.
Class of procedure
Type of procedure
Collection of bodily fluids and microbiological samples
Taking of a blood sample
Taking of a urine sample including by way of a pre-established suprapubic catheter
Taking of a chest secretion sample (excluding bronchoscopy)
Swabbing or scraping of the body including inside of the mouth, nostril or ear canal but excluding the swabbing or scraping of any part of any other body orifice
Radiological imaging
Carrying out of an X-Ray without transferring the person from their existing location
Carrying out of ultrasound imaging without transferring the person from their existing location
Carrying out of transthoracic echocardiography without transferring the person from their existing location
Cardiovascular monitoring
Carrying out of electrocardiogram
Cardiac output monitoring by way of an arterial line
Carrying out of central venous pressure monitoring
Arterial blood pressure monitoring including by way of an arterial line
Respiratory monitoring and support
Measuring of oxygen saturation
Sustaining the appropriate operation of any pre-established airway and ventilatory support
Administration of medication or other product
Administration of antimicrobials
Administration of intravenous fluids
Administration of medication to manage blood pressure
Administration of blood, blood components and blood products
2006 asp. 4. Section 16B was inserted by section 23(1) of the Human Tissue (Authorisation) (Scotland) Act 2019 asp 11 (“the 2019 Act”).